Have your own idea? Try our Stock Screener
Spanish (IBEX) Biotech Industry Analysis
UpdatedMay 02, 2026
DataAggregated Company Financials
Companies4
- 7D0.4%
- 3M-10.5%
- 1Y9.2%
- YTD-12.6%
In the last week, Biotech has been flat. The past year has been better, since the industry has gained 12% in that time. Looking forward, earnings are forecast to grow by 24% annually.
Industry Valuation and Performance
Has the Spanish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 02 May 2026 | €7.5b | €7.8b | €472.3m | 18.7x | 15.9x | 1x |
| Mon, 30 Mar 2026 | €7.1b | €7.8b | €472.3m | 17.6x | 15.1x | 0.9x |
| Wed, 25 Feb 2026 | €8.3b | €7.7b | €401.9m | 30.3x | 20.6x | 1.1x |
| Fri, 23 Jan 2026 | €8.3b | €7.7b | €401.9m | 30.8x | 20.6x | 1.1x |
| Sun, 21 Dec 2025 | €8.2b | €7.7b | €401.9m | 29.3x | 20.4x | 1.1x |
| Tue, 18 Nov 2025 | €8.0b | €7.7b | €401.9m | 28.8x | 19.8x | 1x |
| Thu, 16 Oct 2025 | €8.9b | €7.6b | €332.3m | 30.5x | 26.9x | 1.2x |
| Sat, 13 Sep 2025 | €9.1b | €7.6b | €332.3m | 32.4x | 27.3x | 1.2x |
| Mon, 11 Aug 2025 | €9.5b | €7.6b | €332.3m | 31.4x | 28.7x | 1.2x |
| Wed, 09 Jul 2025 | €8.3b | €7.6b | €208.3m | 54.8x | 39.6x | 1.1x |
| Fri, 06 Jun 2025 | €8.2b | €7.6b | €208.2m | 58.6x | 39.2x | 1.1x |
| Sun, 04 May 2025 | €6.8b | €7.4b | €170.1m | 51.9x | 40.2x | 0.9x |
| Tue, 01 Apr 2025 | €6.8b | €7.4b | €176.3m | 45.1x | 38.5x | 0.9x |
| Thu, 27 Feb 2025 | €7.8b | €7.2b | €154.7m | 1375.4x | 50.3x | 1.1x |
| Sat, 25 Jan 2025 | €7.0b | €7.2b | €154.7m | 1179.5x | 44.9x | 1x |
| Mon, 23 Dec 2024 | €7.2b | €7.2b | €154.7m | 1126.3x | 46.9x | 1x |
| Wed, 20 Nov 2024 | €7.9b | €7.2b | €154.8m | 1072.8x | 50.8x | 1.1x |
| Fri, 18 Oct 2024 | €7.5b | €7.0b | €161.7m | 26.2x | 46.5x | 1.1x |
| Sun, 15 Sep 2024 | €7.2b | €7.0b | €165.5m | 27.6x | 43.8x | 1x |
| Tue, 13 Aug 2024 | €6.0b | €7.0b | €165.5m | 24.2x | 36.6x | 0.9x |
| Thu, 11 Jul 2024 | €7.2b | €6.8b | €189.7m | 36.4x | 38x | 1.1x |
| Sat, 08 Jun 2024 | €6.5b | €6.8b | €189.7m | 33.6x | 34.2x | 1x |
| Mon, 06 May 2024 | €6.0b | €6.8b | €58.6m | 101.8x | 102.5x | 0.9x |
| Wed, 03 Apr 2024 | €5.7b | €6.8b | €55.1m | 264.2x | 103.8x | 0.8x |
| Fri, 01 Mar 2024 | €5.2b | €6.7b | €32.0m | 129.6x | 162.8x | 0.8x |
| Sun, 28 Jan 2024 | €6.7b | €6.7b | €31.4m | 164.8x | 214.3x | 1x |
| Tue, 26 Dec 2023 | €9.4b | €6.7b | €31.5m | 234.8x | 298.9x | 1.4x |
| Thu, 23 Nov 2023 | €8.4b | €6.7b | €31.4m | 208.2x | 268.7x | 1.3x |
| Sat, 21 Oct 2023 | €7.0b | €6.7b | €23.8m | 434.4x | 294.4x | 1.1x |
| Mon, 18 Sep 2023 | €8.7b | €6.7b | €23.8m | 548.3x | 364.8x | 1.3x |
| Wed, 16 Aug 2023 | €8.9b | €6.7b | €23.8m | 558.7x | 372x | 1.3x |
| Fri, 14 Jul 2023 | €8.2b | €6.6b | €69.5m | 101x | 118.3x | 1.3x |
| Sun, 11 Jun 2023 | €7.6b | €6.6b | €69.3m | 93x | 109.9x | 1.2x |
| Tue, 09 May 2023 | €6.6b | €6.3b | €230.9m | 27.4x | 28.6x | 1.1x |
Price to Earnings Ratio
28.6x
Current Industry PE
- Investors are pessimistic on the Spanish Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 15.9x which is lower than its 3-year average PE of 97.1x.
- The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have grown 27% per year over the last three years.
- Revenues for these companies have grown 7.4% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 0.22% | |
| Healthcare | -0.037% | |
| Biotech | 0.40% | |
| Biotech | 0.40% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHM Pharma Mar | €96.00 | 1.4% +€23.4m | 27.1% | PE22.2x | |
| GRF Grifols | €8.96 | 0.1% +€6.8m | 5.1% | PE15.2x | |
| BST Biotechnology Assets | €0.27 | 4.2% +€817.1k | -6.6% | PS6.6x |